Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 6 trials

Late-Stage Pipeline

33%

2 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

6Total
Not Applicable (4)
P 4 (2)

Trial Status

Not Yet Recruiting2
Enrolling By Invitation2
Active Not Recruiting1
Recruiting1

Clinical Trials (6)

Showing 6 of 6 trials
NCT04090359Phase 4RecruitingPrimary

Dual Mobility Acetabular Cups in Revision TJA

NCT05587244Not ApplicableEnrolling By Invitation

G7 Freedom Constrained Vivacit-E Liners

NCT04092634Phase 4Active Not RecruitingPrimary

Dual Mobility in "High Risk" Patients

NCT05548972Not ApplicableEnrolling By Invitation

G7 Dual Mobility With Vivacit-E or Longevity PMCF

NCT06639334Not ApplicableNot Yet Recruiting

The Q-REDUCE Study

NCT04685239Not ApplicableNot Yet RecruitingPrimary

Dual Mobility Cup Versus Unipolar Cup

Showing all 6 trials

Research Network

Activity Timeline